Explore
Validate
Learn
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1105739 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Vascular Cell Adhesion Molecule 1 (VCAM1) antibody
- Antibody type
- Monoclonal
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 1G11B1
- Vial size
- 0.1 mg
- Storage
- Store undiluted at 2-8°C.
Submitted references IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation.
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.
Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins.
The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1.
Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
Stereoscopic mechanisms in monkey visual cortex: binocular correlation and disparity selectivity.
Roussel L, Houle F, Chan C, Yao Y, Bérubé J, Olivenstein R, Martin JG, Huot J, Hamid Q, Ferri L, Rousseau S
Journal of immunology (Baltimore, Md. : 1950) 2010 Apr 15;184(8):4531-7
Journal of immunology (Baltimore, Md. : 1950) 2010 Apr 15;184(8):4531-7
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.
Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, Vos K, Lems WF, Wolbink GJ, Sijpkens D, Dijkmans BA, Tak PP
Annals of the rheumatic diseases 2008 Aug;67(8):1139-44
Annals of the rheumatic diseases 2008 Aug;67(8):1139-44
Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins.
Dienst A, Grunow A, Unruh M, Rabausch B, Nör JE, Fries JW, Gottstein C
Journal of the National Cancer Institute 2005 May 18;97(10):733-47
Journal of the National Cancer Institute 2005 May 18;97(10):733-47
The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1.
Van der Vieren M, Crowe DT, Hoekstra D, Vazeux R, Hoffman PA, Grayson MH, Bochner BS, Gallatin WM, Staunton DE
Journal of immunology (Baltimore, Md. : 1950) 1999 Aug 15;163(4):1984-90
Journal of immunology (Baltimore, Md. : 1950) 1999 Aug 15;163(4):1984-90
Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO
Journal of immunology (Baltimore, Md. : 1950) 1991 Jan 15;146(2):592-8
Journal of immunology (Baltimore, Md. : 1950) 1991 Jan 15;146(2):592-8
Stereoscopic mechanisms in monkey visual cortex: binocular correlation and disparity selectivity.
Poggio GF, Gonzalez F, Krause F
The Journal of neuroscience : the official journal of the Society for Neuroscience 1988 Dec;8(12):4531-50
The Journal of neuroscience : the official journal of the Society for Neuroscience 1988 Dec;8(12):4531-50
No comments: Submit comment
No validations: Submit validation data